Integrum launches short video documentary to showcase the company’s efforts

to treat combat amputees in Ukraine

Mölndal, Sweden – May 3, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B)
announces today that the company has launched a short video documentary about the company’s
Center of Excellence in Kyiv, Ukraine. During Dr Rickard Brånemark’s latest training session at the end
of April, the center was visited by several delegations with politicians, company leaders and military
representatives, and the video documentary was screened to introduce discussions on the future of
trauma healthcare in Ukraine. Among the visitors were the Swedish Minister for Social Services,
Camilla Waltersson Grönvall.

As a result of the Russian invasion, Ukraine’s Health Ministry estimates that there will be approximately
100,000 amputees in Ukraine at the end of 2024. Integrum’s Center of Excellence at the Center for
Complex Endoprosthetics, Osseointegration and Bionics in Kyiv was established in December 2023, with
the intention to spearhead orthopedic treatment using OPRA™ Implant System in individuals who have
suffered limb loss. Integrum’s CEO, Dr Rickard Brånemark, visits the center regularly to perform
surgeries and train surgeons.

To increase awareness of the great need for innovations to help combat amputees, Integrum has
produced a short video documentary showing how the unique technology OPRATM Implant System can
help restore functionality in severely injured veterans. To further increase focus on the matter, Dr
Brånemark has hosted several meetings at the center during the last week with politicians, company
leaders and military representatives.

Among the delegations were The Swedish Minister for Social Services, Camilla Waltersson Grönvall. As
part of the delegation’s visit, the minister met patients who have been treated with Integrum’s OPRATM
Implant System and took part in discussions on the importance of leading trauma healthcare in the
rebuild of Ukraine.

“Integrum aims to restore mobility to individuals who have suffered limb loss. For this reason, we are
very happy and honored to have received acknowledgment from a representative of the top-most
political leadership in Sweden, and the opportunity to discuss the urgent need for purpose-driven
trauma healthcare. We look forward to providing further insight in our area of expertise and continue
the efforts to improve health care for amputees both in Ukraine and globally,” says Rickard Brånemark,
CEO of Integrum.
On May 1, Rickard Brånemark’s was awarded the title of Honorary Military Surgeon by Ukraine’s Head
Surgeon for the Ukraine Military Forces as a recognition for his important work to help combat
amputees.

The video documentary “Integrum’s innovative OPRATM Implant System helps combat amputees in
Ukraine” can be viewed here: Integrum in Ukraine

For more information, please contact:

Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: rickard.branemark@integrum.se

Jörgen Svanström, CFO

Phone: + 46 (0) 70 734 96 60
E-mail: Jorgen.svanstrom@integrum.se

Certified Adviser
Carnegie Investment Bank AB (publ) is Certified Adviser.

About integrum
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside
of Gothenburg, Sweden, with a U.S. subsidiary in San Francisco. Since 1990, its OPRA™ Implant System
has helped improve the quality of life for hundreds of people who are amputees by directly attaching a
prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on
osseointegration, the bone-anchored implant system offers a range of benefits, including improved
mobility and function, enhanced comfort, reduced pressure, a stable attachment and more. The OPRA™
Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only
FDA-approved bone-anchored implant system specifically designed for use in amputees available in the
U.S. Today, Integrum continues to perform research and develop custom-made medical device solutions
in close collaboration with scientists and clinicians. To learn more, please visit https://integrum.se/.